B. Winkfield

New Doppler ultrasound signs improve the non-invasive diagnosis of cirrhosis or severe liver fibrosis

C. Aubé, F. Oberti, P. Calès, 2004, European journal of gastroenterology & hepatology.

[Quality and outcome assessment in gastrointestinal endoscopy: study of 202 colonoscopies].

B. Winkfield, S. Fratté, V. Daucourt, 2008, Presse medicale.

Efficacy, tolerability and safety of low volume bowel preparations in Inflammatory Bowel Diseases: The French multicentre CLEAN study.

A. Amiot, L. Peyrin-Biroulet, X. Dray, 2019, Journal of Crohn's & colitis.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

[Progression of a hepatic hemangioma under progestins].

C. Aubé, P. Calès, B. Winkfield, 2001, Gastroentérologie Clinique et Biologique.

Inter-observer and intra-observer variability in hepatology

C. Aubé, P. Calès, B. Winkfield, 2003, European journal of gastroenterology & hepatology.

A simple and fast LC-MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma.

C. Borg, M. Paillard, Stefano Kim, 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

A. Amiot, B. Bonaz, H. Sokol, 2017, Alimentary pharmacology & therapeutics.

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

A. Amiot, B. Bonaz, H. Sokol, 2018, Alimentary pharmacology & therapeutics.